As all of you may be aware, we have been covering all latest developments about the hasty mass abandonment of trademark applications by the Trade Mark Registry on a regular basis. As per the Registry, such action was taken due to the non-receipt of trademark responses to Examination Reports, within the statutory limit of 30 days.
Earlier this week we reported about the public notice issued by the Controller General of Patents Trademarks and Designs stating the following-
“It is…
In the most recent development in the Ercisson versus CCI battle, the Delhi High Court on the 30th of March, 2016 has dismissed the petition filed by Ericsson in the case of Telefonaktiebolaget LM Ericsson (Publ). v. Competition Commission of India & Anr. In the order passed by Justice Vibhu Bakhru, the court stated that ”Merely because certain reliefs sought by Micromax and Intex before CCI are also available in proceedings under the Patents Act does not exclude the subject…
The Delhi High Court has restrained Glenmark from making and marketing generic versions of Merck Sharp & Dohme (MSD)'s popular antidiabetic drug “Januvia” (sitagliptin) and “Janumet” (combination of sitagliptin and metformin) in its latest order dated October 7, 2015. The order restrains Glenmark from making, using, selling, distributing, advertising, exporting, offering for sale or dealing in Sitagliptin Phosphate Monohydrate or any other salt of Sitagliptin in any form, alone or in combination with one or more other drugs or from…
Working of patents is an integral element of the Indian patent system. In line with the primary objective of patent law, which is to promote the progress of science and technology for public good and economic progress, Indian patent Act specifically mandates working of patents in India. Failing such working, a compulsory license may be granted with respect to a patent , or in the worst case scenario, the patent may be revoked. (See CHAPTER XVI-
WORKING OF PATENTS,COMPULSORY LICENCES AND…